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Weaimedtoconductareviewoftheliteratureforgenepolymorphismsassociatedwithchronicperiodontitis(CP)susceptibility.A
comprehensive search of the literature in English was performed using the keywords: periodontitis, periodontal disease, combined
with the words genes, mutation, or polymorphism. Candidate gene polymorphism studies with a case-control design and reported
genotype frequencies in CP patients were searched and reviewed. There is growing evidence that polymorphisms in the IL1, IL6,
IL10, vitamin D receptor, and CD14 genes may be associated with CP in certain populations. However, carriage rates of the rare
(R)-allele of any polymorphism varied considerably among studies and most of the studies appeared under-powered and did
not correct for other risk factors. Larger cohorts, well-deﬁned phenotypes, control for other risk factors, and analysis of multiple
genes and polymorphisms within the same pathway are needed to get a more comprehensive insight into the contribution of gene
polymorphisms in CP.
1.Introduction
Periodontitislikemanyothercommondiseases(e.g.,Crohn’s
disease, cardiovascular diseases, diabetes) is considered to
be a complex multifactorial disease. Typical for complex
human diseases is that they mostly have a relatively mild
phenotype and are slowly progressing and chronic in nature.
Furthermore, these diseases are of relative late of onset (i.e.,
postjuvenile or adult onset) and are relatively common.
The phenotype of the complex diseases is determined by
both genetic and the environmental factors that aﬀect the
individual. Although pathogenic bacteria and various other
environmental factors (e.g., smoking and stress) [1]a r e
involved in pathogenesis of periodontitis, also genetic factors
are evidenced in the aetiology of periodontitis [2, 3].
Understanding of the interplay between the host and oral
bacteria is essential to the understanding of the pathogenesis
ofperiodontaldisease.Periodontopathicbacteriainitiateand
repeatedly attack the host, which subsequently reacts with
immune response and may slowly destruct by the action
of the inﬂammatory process itself. However, the presence
of pathogenic subgingival bacteria alone does not result in
periodontal destruction in most cases. Therefore, although
bacteria are essential for the initiation of periodontitis, the
amount of plaque and the species of bacteria does not
necessarily correlate with disease severity [4]. Each person
may have an individual dose dependend response to the
bacterial challenge that determines his/her susceptibility to
periodontitis. Most individuals are resistant to the disease
and will not develop periodontitis.
There are a large number of scientiﬁc papers searching
for the role of genes and their variants (polymorphisms)
in host responses in periodontitis, and in the progression
of the disease. The genetic polymorphisms may in some
situations cause a change in the protein or its expression
possibly resulting in alterations in innate and adaptive
immunityandmaythusbedeterministicindiseaseoutcome.
Genetic polymorphisms may also be protective for a disease.
The pathophysiology of periodontitis, as of other complex
diseases, is characterized by various biological pathways
leading to the same clinical phenomena. Multiple genes
and their polymorphisms may all have a small overall
contribution and relative risk to disease susceptibility and
severity. Complex diseases are typically polygenic [23]. The2 International Journal of Dentistry
Table 1: IL1A -889 (+4845) C>T gene polymorphisms and carriage rate of the Rare (R)-allele in case-control studies and association with
susceptibility to chronic periodontitis.
Patients Controls
Ethnicity n R-allele N R-allele Associated Reference
of subjects carriage carriage with periodontitis
Caucasian 322 43% 32 38% − Gore et al.1998 [5]
Caucasian 1052 64% 53 60% − (+4) Laine et al. 2001 [6]
Caucasian 61 43% 800 50% − Thomson et al. 2001 [7]
Caucasian 841 48% 60 45% − Rogers et al. 2002 [8]
Caucasian 45 53% 110 43% − Sakellari et al. 2003 [9]
Caucasian 57 72% 100 56% − B r e t te ta l . 2005 [10]
Caucasian 3303 44% 101 35% − Lopez et al. 2005 [11]
Caucasian 56 54% 90 49% − Sakellari et al. 2006 [12]
Caucasian 51 55% 178 43% − Tervonen et al. 2007 [13]
Caucasian 97 90% 97 79% + Wagner et al. 2007 [14]
Caucasian 8932 54% 493 49% − Struch et al. 2008 [15]
Caucasian 511 71% 168 60% − Geismar et al. 2008 [16]
Mixed1 83 69% 37 52% − Shirodaria et al. 2000 [17]
Asian (Thai) 54 8% 43 23% − Anusaksathien et al. 2003 [18]
Japanese 583 14% 44 16% − Kobayashi et al. 2007 [19]
Japanese 1003 20% 100 16% − Kobayashi et al. 2007 [20]
Brazilian 29 14% 17 23% − Gonc ¸alveset al. 2006 [21]
Brazilian 67 60% 41 41% + Moreira et al. 2007 [22]
nr = not reported. − = association not found. + = association found.
163% Caucasian; 22% Asian; 15% Afro-Caribean.
2Cases diagnosed as adult periodontitis.
3Cases diagnosed as mixed periodontitis status.
4An association with periodontitis was found for combined genotype: carriage of R-allele for IL1A -889, IL-1B +3954, and IL1RN in a subgroup of patients
being nonsmokers, and at the same time culture negative for P. gingivalis and A. actinomycetemcomitans.
disease genes in complex diseases are therefore considered
modifying disease genes [24]. It is important to realize that
thenumberandtypeofmodifying diseasegenesforthesame
disease may not be same in diﬀerent ethnic populations.
In the present review we explore and summarize literature
up to April 2009 on putative genetic risk factors in chronic
periodontitis (CP) susceptibility.
2.TheR oleofGeneticsinChronicP eriodontitis
Evidence for the role of genetic component in chronic
(adult) periodontitis has been conducted from twin and
family studies. The twin model is probably the most
powerful method to study genetic aspects of any disease,
including periodontal disease. Michalowicz et al. evaluated
the periodontal conditions (attachment loss, pocket depth,
gingival index, and plaque index) of 110 adult twins with
a mean age of 40 years ranging from 16 to 70 years [3].
The results indicate that between 38% and 82% of the
population variance for these measures may be attributed to
genetic factors. In a study on 117 adult twin pairs [2] the
analysis included the evaluation of the environmental factors
like smoking and utilization of dental services. The results
showed that chronic (adult) periodontitis was estimated to
have approximately 50% heritability, which was unaltered
following adjustments for behavioral variables including
smoking. In contrast, there was no evidence of heritability
for gingivitis after behavioral covariates such as utilization
dental care and smoking were incorporated in the analysis.
Velden et al. [33] studied with a family study design the
eﬀect of sibling relationship on the periodontal condition in
a group of young Indonesians deprived from regular dental
care. The results of the analysis suggest that also in less severe
forms of periodontitis there may be a genetic background
for the disease. Also in a Dutch population epidemiological
studies have suggested that chronic (adult) periodontitis
aggregates in families [34].
From both the twin and family studies it can be con-
cluded that the basis for familial aggregation of periodontitis
appears not bacterial/environmental/behavioral in nature;
rather, genetics seem to form the basis for the familial
aggregation of periodontitis.
3. Strategy of the Recovery of Published Data
A comprehensive literature search on the PubMed database
up to April 2009 was conducted using the keywords:
Periodontitis, Periodontal disease, in combination with the
words Genes, Mutation, or Polymorphism. The studies
selected for the review (1) were written in English, (2)International Journal of Dentistry 3
Table 2: IL1B +3954 (+3953) C>T gene polymorphisms and carriage rate of the Rare (R)-allele in case-control studies and association with
susceptibility to chronic periodontitis.
Patients Controls
Ethnicity n R-allele n R-allele Associated Reference
of subjects carriage carriage with periodontitis
Caucasian 321 43% 32 38% − Gore et al. 1998 [5]
Caucasian 401 50% 45 27% + Galbraith et al. 1999 [25]
Caucasian 1051 49% 53 45% − (+3) Laine et al. 2001 [6]
Caucasian 61 34% 800 41% − Thomson et al. 2001 [7]
Caucasian 841 35% 60 40% +4 Rogers et al. 2002 [8]
Caucasian 281 46% 33 48% − Gonzales et al. 2003 [26]
Caucasian 45 49% 110 50% − Sakellari et al. 2003 [9]
Caucasian 57 42% 100 41% − B r e t te ta l . 2005 [10]
Caucasian 3302 30% 101 13% + Lopez et al. 2005 [11]
Caucasian 32 34% 52 40% − Dro´ zdzik et al. 2006 [27]
Caucasian 13 33% 13 33% − Gustafsson et al. 2006 [28]
Caucasian 56 41% 90 44% − Sakellari et al. 2006 [12]
Caucasian 51 49% 178 44% − Tervonen et al. 2007 [13]
Caucasian 97 74% 97 43% + Wagner et al. 2007 [14]
Caucasian 511 57% 168 43% − Geismar et al. 2008 [16]
Caucasian 8931 44% 493 39% −5 Struch et al. 2008 [15]
Asian (Thai) 54 0% 43 2% − Anusaksathien et al. 2003 [18]
Japanese 641 6% 64 10% − Soga et al. 2003 [29]
Japanese 582 5% 44 7% − Kobayashi et al. 2007 [19]
Japanese 1002 6% 100 6% − Kobayashi et al. 2007 [20]
Brazilian 52 44% 31 23% + Moreira et al. 2005 [30]
Brazilian 29 28% 17 18% − Gonc ¸alveset al. 2006 [21]
Brazilian 117 39% 175 31% − Ferreira et al. 2008 [31]
Indian 30 30% 31 23% − Kaarthikeyan et al. 2009 [32]
nr = not reported. − = association not found. + = association found.
1Cases diagnosed as adult periodontitis.
2Cases diagnosed as mixed periodontitis status.
3An association with periodontitis was found for combined genotype: carriage of R-allele for IL1A -889, IL1B +3954, and IL1RN in a subgroup of patients
being nonsmokers, and at the same time culture negative for P. gingivalis and A. actinomycetemcomitans.
4N-allele is associated with CP.
5R-allele is not quit associated with CP (P = .07).
had a case-control design including patients with chronic
(CP) or adult (AP) periodontitis, and (3) reported genotype
distribution.
In the preparation of this review we encountered various
nomenclatures for the diagnosis of cases and controls, and
during the years, the nomenclature for the diagnosis of the
various forms of periodontitis has changed. In this paper we
have used the diagnosis of periodontitis from the original
manuscripts as much as possible. We focussed on the role of
genetic polymorphisms (mainly single nucleotide polymor-
phisms [SNPs]) in chronic periodontitis (CP) susceptibility.
In the present review, the most common variant of the
polymorphic locus in the study population is nominated as
a normal variant (N-allele). Thus, if a locus is, for example,
bi-allelic, the less frequent allele is designated as a rare
variant (R-allele) but must occur with a frequency of >1%
in the population. We present in the tables the frequency
of the carriage rate of the R-allele (frequency of N/R and
R/R genotypes) among cases and controls. In addition we
present in the tables whether or not the authors of the
cited papers have reported statistically signiﬁcant diﬀerences
between cases and controls for a given R-allele.
Most genetic research in periodontitis has focused on
gene polymorphisms that play a role in the immune system,
tissue destructive processes, or metabolism mechanisms.
Tables 1–12 present the candidate gene polymorphisms
investigated in relation to CP susceptibility. In this review
a polymorphism was considered to be associated with CP
susceptibility if a polymorphism has been investigated in
several studies and the association has been replicated
at least once. Below we discuss the ﬁndings of various
epidemiological studies that were undertaken to further
understandtherolesofgenepolymorphismsinsusceptibility
to chronic periodontitis.4 International Journal of Dentistry
Table 3: IL1B -511 (-31) and IL1RN VNTR (+2018) gene polymorphisms and carriage rate of the Rare (R)-allele in case-control studies and
association with susceptibility to chronic periodontitis.
Patients Controls
IL1 gene Ethnicity of subjects n R-allele n R-allele Associated Reference
polymorphism carriage carriage with periodontitis
B -511 (-31) C>T
Caucasian 321 59% 32 59% − Gore et al. 1998 [5]
Caucasian 57 53% 100 49% − Brett et al. 2005 [10]
Caucasian 511 43% 168 56% − Geismar et al. 2008 [16]
Japanese 641 67% 64 78% − Soga et al. 2003 [29]
RN VNTR (+2018 C>T)
Caucasian 1051 46% 53 38% − (+3) Laine et al. 2001 [6]
Caucasian 51 45% 190 7% + Berdeli et al. 2006 [35]
Caucasian 56 45% 90 30% − Sakellari et al. 2006 [12]
Caucasian 511 34% 168 44% − Geismar et al. 2008 [16]
Japanese 1002 6% 100 13% − Kobayashi et al. 2007 [20]
nr = not reported. − = association not found. + = association found.
1Cases diagnosed as adult periodontitis.
2Cases diagnosed as mixed periodontitis status.
3An association with periodontitis was found for combined genotype: carriage of R-allele for IL1A -889, IL1B +3954, and IL1RN in a subgroup of patients
being non-smokers and culture negative for P. gingivalis and A. actinomycetemcomitans.
Table 4: IL1 composite genotype, that is, Rare (R)-allele carriage at IL1A -889 (+4845) and IL1B +3954 (+3953) [36], in case-control studies
and association with susceptibility to chronic periodontitis.
Patients Controls
Ethnicity n R-allele n R-allele Associated Reference
of subjects carriage carriage with periodontitis
Caucasian 322 34% 32 28% − Gore et al. 1998 [5]
Caucasian1 44 41% 46 28% + McDevitt et al. 2000 [37]
Caucasian 1052 46% 53 42% − Laine et al. 2001 [6]
Caucasian 1323 45% 73 42% − Papapanou et al. 2001 [38]
Caucasian 61 28% 800 35% − Thomson et al. 2001 [7]
Caucasian 842 26% 60 30% − Rogers et al. 2002 [8]
Caucasian 402 38% 414 34% − (+4) Meisel et al. 2003 [39]
Caucasian 45 34% 110 30% − Sakellari et al. 2003 [9]
Caucasian 3303 26% 101 10% + Lopez et al. 2005 [11]
Caucasian 56 41% 90 44% − Sakellari et al. 2006 [12]
Chinese 2442 0% 56 3% − Armitage et al. 2000 [40]
Asian (Thai) 54 0% 43 2% − Anusaksathien et al. 2003 [18]
Japanese 1003 0.2% 100 0.2% − Kobayashi et al. 2007 [20]
Indian 90 14% 30 0% + Agrawal et al. 2006 [41]
Brazilian 29 3% 17 12% − Gonc ¸alves et al. 2006 [21]
nr = not reported. − = association not found. + = association found.
182% of study population is of Caucasian heritage; results found after multiple logistic regression analysis correcting for smoking status and age.
2Cases diagnosed as adult periodontitis.
3Cases diagnosed as mixed periodontitis status.
4In smokers.
4. CandidateGenesin Relation to
ChronicPeriodontitis(CP)
4.1. Polymorphisms in the IL1 Gene Cluster. Interleukin-1
(IL-1) is a potent proinﬂammatory mediator that is mainly
released by monocytes, macrophages, and dendritic cells.
Levels of IL-1α and IL-1β, (proinﬂammatory cytokines)
and IL-1/IL-receptor antagonist (RA, antiinﬂammatory
cytokine) ratio have been found to be increased in diseased
periodontal tissues and gingival grevicular ﬂuid [53, 54].
The genes encoding for the proteins IL-1α,I L - 1 β,a n d
IL-1RA are located in close proximity in the IL1 gene
cluster on chromosome 2q13–q21. The IL1A -889 and IL1B
+3953 R-alleles have been shown to increase and the IL1RN
VNTR R-alleles to decrease gene transcription or the protein
production levels [17, 55, 56] resulting in the R-allele carrier
individuals in a more pronounced IL-1 pro-inﬂammatory
response.International Journal of Dentistry 5
Table 5: TNFA gene polymorphisms and carriage rate of the Rare (R)-allele in case-control studies and association with susceptibility to
chronic periodontitis.
Patients Controls
TNFA gene Ethnicity n R-allele n R-allele Associated Reference
polymorphism of subjects carriage carriage with periodontitis
-1031 T>C Japanese 642 36% 64 22% + Soga et al. 2003 [29]
-863 C>A Japanese 642 39% 64 25% + Soga et al. 2003 [29]
-857 C>T Japanese 642 39% 64 28% + Soga et al. 2003 [29]
-367 G>AM i x e d 1 90 2% 264 2% − Craandijk et al. 2002 [42]
-308 G>A
Caucasian 322 28% 32 24% − Galbraith et al. 1998 [43]
Caucasian 402 20% 45 24% +3 Galbraith et al. 1999 [25]
Caucasian 132 21% 114 24% − Fassmann et al. 2003 [44]
Caucasian 81 36% 80 28% − Folwaczny et al. 2004 [45]
Caucasian 60 22% 39 18% − Donati et al. 2005 [46]
Caucasian 57 35% 100 40% − Brett et al. 2005 [10]
Caucasian 56 16% 90 27% − Sakellari et al. 2006 [12]
Caucasian 51 31% 178 23% − Tervonen et al. 2007 [13]
Caucasian 54 31% 52 35% − Schulz et al. 2008 [47]
Mixed1 90 27% 264 29% − Craandijk et al. 2002 [42]
Japanese 642 2% 64 3% − Soga et al. 2003 [29]
Brazilian 74 31% 51 44% − De Menezes et al. 2008 [48]
-238 G>A
Caucasian 322 6% 32 6% − Galbraith et al. 1998 [43]
Caucasian 54 9% 52 15% − Schulz et al. 2008 [47]
Mixed1 90 6% 264 6% − Craandijk et al. 2002 [42]
Japanese 642 0% 64 3% − Soga et al. 2003 [29]
+489 G>AM i x e d 1 90 24% 264 19% − Craandijk et al. 2002 [42]
nr = not reported. − = association not found. + = association found.
181% of study population is of Caucasian heritage.
2Cases diagnosed as adult periodontitis.
3N/N genotype is associated with CP.
The IL1 genotypes appear to be the most studied genetic
polymorphisms in CP (Tables 1–4). Kornman et al. [36]
reported on a composite genotype, composed of the IL1A
-889 and IL1B +3953 polymorphisms both carrying an
R-allele, in relation to periodontitis. To date, the following
IL1 genetic polymorphisms have been studied in association
with chronic periodontitis: IL1A -889 (in linkage disequi-
librium with +4845), IL-1B -511 (in linkage disequilibrium
with -31), IL1B +3954 (also mentioned in the literature as
+3953), and IL1RN VNTR (in linkage disequilibrium with
+2018).
Results of case-control studies in Caucasians and non-
Caucasians are presented in Tables 1–4. From the tables
it becomes clear that among the diﬀerent studies even
exclusively within Caucasian subjects, considerable variation
is seen for the carriage rates of the IL1 R-alleles. For example,
for the polymorphic IL1A -889 (+4845) (Table 1), the car-
riage rate for the R-allele varies from 43% to 90% in patients
and from 35% to 79% in controls. The carriage rate of the
IL1A -889 (+4845) R-allele in Asian populations appears
low (8%–23%) [18, 20] in comparison to other populations.
The latter ﬁnding demonstrates an important issue, that is,
the carriage rate of genetic polymorphisms may vary among
diﬀerent ethnic populations. Therefore, possible positive
associations between a genetic polymorphism and disease
within one population may not necessarily be extrapolated
tootherpopulations.Onlytwostudies[14,22]ha v er eported
on an association between the carriage rates of the IL1A -889
R-alleles and CP as a single genetic risk factor.
The SNP IL1B +3954 (+3953) was initially proposed
as risk factor for periodontitis among Caucasians (Table 2).
Neverthelessthereareconﬂictingresults.Galbraithetal.[25]
found an association between the R-allele and periodontitis,
and Gore et al. [5] observed an association with the severity
of periodontal destruction. Also Lopez et al. [11], Moreira
et al. [30], and Wagner et al. [14] have associated the IL1B
+3954 R-allele with CP. However, Rogers et al. [8] did not
ﬁnd the association for the R-allele but for the N-allele in CP.
Among Asian subjects, the carriage rate of the IL1B +3954
(+3953) R-allele is importantly lower (≤10%) [18, 20, 29]
than that in Caucasian populations (13%–74%) (Table 2).
Struch et al. [15] have performed a large scale study on the
IL1B +3954 polymorphism in a Caucasian population: in a
group of 893 CP patients and 493 controls carriage rates for
the R-allele were 44% and 39%, respectively, which was not
signiﬁcant (P = .07).
Four studies have reported carriage rates for the IL1B -
511 (-31) R-allele, and to date this genetic polymorphism6 International Journal of Dentistry
Table 6: IL4 and IL4RA gene polymorphisms and carriage of the Rare (R)-allele in case-control studies, and association with chronic
susceptibility to periodontitis.
Patients Controls
IL4 gene Ethnicity of subjects n R-allele n R-allele Associated Reference
polymorphism carriage carriage with periodontitis
-33 C>T
Caucasian 194 32% 158 25% − (+2) Holla et al. 2008 [49]
Brazilian 69 68% 44 57% − Scarel-Caminaga et al. 2003 [50]
African-American 301 87% 30 81% − Pontes et al. 2004 [51]
-590 C>T
Caucasian 194 32% 158 25% − (+2) Holla et al. 2008 [49]
Iranian 26 33% 56 52% − Hooshmand et al. 2008 [52]
African-American 301 67% 30 57% − Pontes et al. 2004 [51]
VNTR intron 3 Caucasian 194 31% 158 25% − (+2) Holla et al. 2008 [49]
RA Q551R Caucasian 60 45% 39 39% − Donati et al. 2005 [46]
nr = not reported. − = association not found. + = association found.
1Cases diagnosed as mixed periodontitis status.
2Haplotype T(-590)/T(-33)/allele 2 (70bp) is associated with CP (17.0% cp versus 11.0%; OR 1.85).
has not been associated with CP (Table 3). The carriage of
the R-allele was higher among Japanese (67%) than among
Caucasians (43%–59%) [5, 10, 16, 29].
Few studies have investigated polymorphisms in the
IL1RN gene, encoding the IL-1RA (Table 3) and again con-
ﬂictingresultsarereported.TheR-allelecarriageisassociated
as a single genetic risk factor with CP (45% versus 7% in
controls) in Turkish Caucasians [35]. In combination with
IL1A -889 and IL1B +3954, the IL1RN R-allele was reported
to have a relationship with periodontitis susceptibility [6].
Kornman et al. [36] reported that the combined presence
of the R-allele of the IL1A !gene at nucleotide position –
889 and the R-allele of the IL1B. gene at nucleotide position
+3954 (+3953) was associated with severity of periodontitis
in nonsmoking Caucasian patients. This combined carriage
rate of the R-alleles was designated the IL1 composite
genotype [36]. Since that time a considerable number
of studies investigating the IL1 composite genotype have
been published in Caucasians and non-Caucasians (Table 4).
Studies on Caucasian populations have shown prevalence
from 10% to 46% for the composite genotype, whereas
among Asian populations [18, 20, 40] prevalence of the IL1
composite genotype was very low (≤3%).
AftertheinitialresultsofKornmanetal.[36],manycase-
control studies have investigated the IL1 composite genotype
as a putative risk factor for CP susceptibility, mostly in
Caucasian populations (Table 4). Two studies have observed
an association between the IL1 composite genotype and
periodontitis susceptibility in Caucasians [11, 37]a n do n e
study in non-Caucasians [41]. Meisel et al. [39] observed the
IL1 composite genotype to be associated with periodontitis
in Caucasian but only in smokers. However, all other
studies have failed to replicate this association (Table 4).
Nevertheless, it has also been reported that patients with
the IL1 composite genotype more often harbored putative
periodontal pathogens and have increased counts of these
pathogens [147]. Interestingly, Laine et al. [6]r e p o r t e d
increased frequency of the R-alleles of the IL1A, IL1B,
and IL1RN genes in non-smoking patients in whom the
periodontal pathogens Porphyromonas gingivalis and Aggre-
gatibacter actinomycetemcomitans could not be detected.
These latter results suggest that IL1 gene polymorphisms
may play a role in the absence of other (putative) risk
factors.
Taken altogether, the IL1 gene cluster polymorphisms
cannot be considered as risk factors for CP susceptibility
for the worldwide population. However, for Caucasian CP
patients the IL1 composite genotype and/or IL1B +3953
genotype may be genetic risk factors. Results of the meta-
analysis of Nikolopoulos et al. [148] support also an
association between CP and IL1A -889 and IL1B +3953 R-
allele carriage as well separately as in composite genotype in
Caucasians.
4.2.PolymorphismsintheTNFAGene. Tumornecrosisfactor
(TNF) is a proinﬂammatory cytokine that possesses a wide
range of immunoregulatory functions. TNF is produced
by monocytes, macrophages, and lymphocytes and has the
potential to stimulate the production of secondary medi-
ators, including chemokines or cyclooxygenase products,
which consequently amplify the degree of inﬂammation.
The TNFA gene is located on chromosome 6p21.3 within
the Major Histocompatibility Complex gene cluster. Several
case-control studies in both Caucasians and non-Caucasians
have investigated genetic polymorphisms in the TNFA gene
as putative risk factors for periodontitis. SNPs in the gene
encoding TNFA are mainly studied in the promoter region
at positions -1031, -863, -857, -376, -308, and -238 but also
in the coding region in the ﬁrst intron at position +489. The
results of these studies are summarized in Table 5.
The diﬀerences in the carriage rate of the R-alleles
between Japanese and other populations are apparent; at
position -308 the R-allele carriage rates for Japanese subjects
were only 2%-3% (Table 5)[ 29] and for other populations
18%–44% [10, 12, 13, 25, 43–47]. For the TNFA -238 the
frequencies of R-alleles were comparable between diﬀerentInternational Journal of Dentistry 7
Table 7: IL6 and IL6R gene polymorphisms and carriage of the Rare (R)-allele in case-control studies and association with susceptibility to
chronic periodontitis.
Patients Controls
IL6 gene Ethnicity n R-allele n R-allele Associated Reference
polymorphism of subjects carriage carriage with periodontitis
-174 G>C
Caucasian 148 77% 107 84% − Holla et al. 2004 [57]
Caucasian 57 61% 100 44% + B r e t te ta l . 2005 [10]
Caucasian 124 42% 116 28% +2 Babel et al. 2006 [58]
Caucasian 137 65% 82 62% − Wohlfahrt et al. 2006 [59]
Caucasian 51 78% 178 79% − Tervonen et al. 2007 [13]
Caucasian 326 61% 144 71% +3
Afro-American 93 10% 45 16% − Nibali et al. 2009 [60]
Asian 87 20% 29 24% −
Brazilian 48 37% 36 67% +4 Trevilatto et al. 2003 [61]
Japanese 112 0% 77 0% − Komatsu et al. 2005 [62]
Brazilian 1551 44% 54 37% − Moreira et al. 2007 [63]
-190 C>T Japanese 112 0% 77 0% − Komatsu et al. 2005 [62]
-572 C>G
Caucasian 148 6% 107 20% +4 Holla et al. 2004 [57]
Japanese 112 37% 77 47% − Komatsu et al. 2005 [62]
Caucasian 326 10% 144 8% −
Afro-American 93 21% 45 13% − Nibali et al. 2009 [60]
Asian 87 61% 29 55% −
-373 Japanese 112 12% 77 21% +5 Komatsu et al. 2005 [62]
(A(n)T(m) (A9T11) (A9T11)
-597 G>A Caucasian 148 78% 107 84% − Holla et al. 2004 [57]
Japanese 112 0% 77 0% − Komatsu et al. 2005 [62]
-1363 G>T
Caucasian 326 14% 144 22% +
Afro-American 93 1% 45 4% − Nibali et al. 2009 [60]
Asian 87 5% 29 14% −
-1480 C>G
Caucasian 326 58% 144 56% −
Afro-American 93 8% 45 16% − Nibali et al. 2009 [60]
Asian 87 19% 29 24% −
-6106 A>T
Caucasian 326 38% 144 37% −
Afro-American 93 36% 45 38% − Nibali et al. 2009 [60]
Asian 87 38% 29 48% −
R +48892 A>C Japanese 169 66% 70 66% − (+6) Galicia et al. 2006 [64]
R -183 G>A Japanese 169 76% 70 74% − Galicia et al. 2006 [64]
nr = not reported. − = association not found. + = association found.
1Cases diagnosed as mixed periodontitis status.
2Only R/R genotype frequency is reported and is associated with CP
3IL-6 -174, -1363, and -1480 haplotype is associated with periodontitis.
4N/N genotype is associated with CP.
5Carriage rate of the -373 A9T11 allele higher in non-CP.
6N-allele is associated with CP.
ethnic populations (<15%) (Table 5). For the other TNFA
polymorphisms only single studies have been reported, and
positive associations with CP have been found for the -1031,
-863, and -857 loci [29].
To date there is very limited data to support associations
between any of the reported TNFA gene variations and
CP susceptibility. Although the SNP’s TNFA -1031, -857,
and -863 showed an association with CP in Japanese, these
ﬁndings have not been replicated [29].
4.3. Polymorphisms in the IL4 and IL4RA Genes.
Interleukine-4 (IL-4) is a pleiotropic cytokine, which is
produced by the T helper 2 cell subpopulation and can
rescue B lymphocytes from apoptosis and enhance their
survival, thus promoting B-lymphocyte mediated immunity.
IL-4 also downregulates macrophage function [149]. The
gene for IL4 has been located on chromosome 5q31.1.
Gene polymorphisms studied in the IL4 gene are sum-
marized in Table 6.A nIL4 -590 promoter polymorphism8 International Journal of Dentistry
Table 8: IL10 gene polymorphisms and carriage rate of the Rare (R)-allele in case-control studies and association with susceptibility to
chronic periodontitis.
Patients Controls
IL10 gene Ethnicity n R-allele n R-allele Associated Reference
polymorphism of subjects carriage carriage with periodontitis
-1087 (-1082) A>G
Caucasian 60 77% 39 69% − (+3) Berglundh et al. 2003 [65]
Caucasian 57 67% 100 69% − Brett et al. 2005 [10]
Caucasian 118 69% 114 74% − Babel et al. 2006 [58]
Caucasian 51 63% 178 70% − Tervonen et al. 2007 [13]
Caucasian 27 81% 34 70% − Reichert et al. 2008 [66]
Mixed1 67 49% 43 61% Scarel-Caminaga et al. 2004 [67]
(Caucasian) (48) (44%) (36) (61%) (−)
-819 (-824) C>T
Caucasian 27 26% 34 32% − Reichert et al. 2008 [66]
Mixed1 67 76% 43 51% + Scarel-Caminaga et al. 2004 [67]
(Caucasian) (48) (77%) (36) (47%) (+)
Turkish 75 56% 73 45% − Sumer et al. 2007 [68]
-627 C>A Caucasian 57 32% 100 40% − Brett et al. 2005 [10]
-592(-597) C>A
Mixed1 67 72% 43 51% + Scarel-Caminaga et al. 2004 [67]
(Caucasian) (48) (75%) (36) (47%) (+)
Mixed2 116 71% 173 51% + Claudino et al. 2008 [69]
Turkish 75 68% 73 41% + Sumer et al. 2007 [68]
-590 C>A Caucasian 27 26% 34 32% − Reichert et al. 2008 [66]
nr = not reported. − = association not found. + = association found.
176% of CP and 84% of the control population were Caucasians.
278% of CP and 79% of the control population were Caucasians.
3N-allele associated with periodontitis, in particular non-smoking homozygous N/N subjects.
and a 70-bp VNTR polymorphism are the most studied
polymorphisms of IL4. Case–control studies have not shown
any relationship between the IL4 gene polymorphims and
susceptibility to CP in several diﬀerent populations. How-
e v e r ,ah a p l o t y p eo fIL4 polymorphisms (carriers of R-alleles
in all three SNPs studied) has been associated with CP
(17.0% in cases versus 11.0% in controls; OR 1.85) [49].
No association was found for the IL4RA polymorphims in
a study on Caucasians [46].
4.4. Polymorphisms in the IL6 and IL6R Genes. Multiple roles
have been identiﬁed for interleukine-6 (IL-6). It is released
by diﬀerent cell types and its secretion levels are determined
by the cell type and the nature of the stimulus [150, 151].
The IL6 gene was demonstrated to be localized on chromo-
some 7p21. IL6 polymorphisms aﬀect the serum levels of
circulating interleukin-6. The -174 was found to inﬂuence
IL-6 expression and production. The -174 R-allele carrier
individuals have decreased plasma levels of IL-6 and present
lower IL6 gene transcriptional activity when compared with
N/N individuals [152]. Therefore a genetically determined
low IL-6 response (the -174 R-allele carriers) may hamper
individual’s defense against periodontal pathogens.
The carriage rates of the IL6 -174 R-allele varied in
Caucasian populations from 44% to 54%, in Brazilian
populations from 37% to 67%, and remarkably, the -174 as
wellas-190and-597lociwerenonpolymorphicinaJapanese
population (Table 7). Three out of six studies in Caucasian
and one out of two studies in Brazilian populations have cor-
related the IL6 -174 G>C polymorphism with susceptibility
to CP. With regard to the other IL6 gene polymorphisms, the
Czech study [57] suggested that the -572 polymorphism may
be a protective factor to CP. Furthermore, for the other IL6
polymorphisms only single studies have been reported.
We conclude that the IL6 -174 polymorphism may be
associated with CP susceptibility. However, a meta-analysis
of the IL6 -174 polymorphisms did not show any association
for this polymorphism with CP [148].
4.5.PolymorphismsintheIL10Gene. Interleukine-10(IL-10)
is considered an antiinﬂammatory cytokine, downregulating
the proinﬂammatory immune response of the monocytes
and macrophages. However, the B lymphocyte stimulatory
eﬀect may also stimulate the production of autoantibodies
[153]. As a matter of fact, auto-antibodies may play a role
in periodontitis [154–156]. IL-10 is produced by monocytes,
macrophages, and T cells and plays a role in the regulation of
proinﬂammatory cytokines such as IL-1 and TNF-α.
The gene encoding for IL-10 is mapped on chromosome
1q31-q32, in a cluster with closely related interleukin
genes, including IL-19, IL-20, and IL-24. Several promoter
polymorphisms have been described in the IL10 gene: -
1087 (-1082), -819 (-824), -627, -592 (-597), and -590
(Table 8). The IL-10 -1082, -819, and -592 polymorphisms
show strong linkage disequilibrium and form two common
haplotypes. The haplotypes may be determined on basis of
the IL10 -592 polymorphism [69]. The R-allele of the -592International Journal of Dentistry 9
Table 9: FcγRIIa, FcγRIIIa, and FcγRIIIb gene polymorphisms and carriage rate of the Rare (R)-allele in case-control studies and association
with susceptibility to chronic periodontitis.
Patients Controls
FcγR gene Ethnicity n R-allele N R-allele Associated Reference
polymorphism of subjects carriage carriage with periodontitis
IIa 131 H>R
Caucasian1 54 76% 24 71% − Colombo et al. 1998 [70]
Caucasian 56 70% 61 75% − Loos et al. 2003 [71]
Caucasian 213 63% 209 75% − (+4) Yamamoto et al. 2004 [72]
Caucasian 132 72% 72 74% − Wolf et al. 2006 [73]
Japanese2 100 44% 105 40% − Kobayashi et al. 1997 [74]
Japanese2 83 46% 104 39% − Kobayashi et al. 2000 [75]
Japanese 89 42% 64 42% − Kobayashi et al. 2001 [76]
Taiwanese 50 50% 74 62% − Chung et al. 2003 [77]
Japanese 583 48% 44 36% − Kobayashi et al. 2007 [19]
Japanese 1003 44% 100 39% − Kobayashi et al. 2007 [20]
IIIa 158 F>V
Caucasian 56 73% 61 59% − Loos et al. 2003 [71]
Japanese2 100 42% 104 46% − Sugita et al. 1999 [78]
Japanese2 83 43% 104 46% − Kobayashi et al. 2000 [75]
Japanese 89 49% 64 39% − Kobayashi et al. 2001 [76]
Japanese 583 40% 44 45% − Kobayashi et al. 2007 [19]
Japanese 1003 45% 100 45% − Kobayashi et al. 2007 [20]
IIIb NA1> NA2
Caucasian1 54 89% 24 75% − Colombo et al. 1998 [70]
Caucasian 56 88% 61 92% − Loos et al. 2003 [71]
Caucasian 132 84% 72 89% − Wolf et al. 2006 [73]
Japanese2 100 63% 105 64% − Kobayashi et al. 1997 [74]
Japanese2 83 64% 104 64% − Kobayashi et al. 2000 [75]
Japanese 89 62% 64 56% − Kobayashi et al. 2001 [76]
Japanese2 73 74% 46 56% + Sugita et al. 2001 [79]
Japanese2 52 58% 55 57% − Yoshihara et al. 2001 [80]
Taiwanese 50 62% 74 55% − Chung et al. 2003 [77]
Japanese 583 66% 44 55% − Kobayashi et al. 2007 [19]
Japanese 1003 66% 100 64% − Kobayashi et al. 2007 [20]
nr = not reported. − = association not found. + = association found.
1Mainly Caucasian, actual % of subjects of non-Caucasian heritage is not provided.
2Cases diagnosed as adult periodontitis.
3Cases diagnosed as mixed periodontitis status
4N-allele is associated with periodontitis in smokers.
polymorphism has been associated with decreased synthesis
o fI L - 1 0i nv i t r oa n di nv i v o[ 157, 158]a n dm a yl e a d
to altered synthesis of IL-10 in response to inﬂammatory
stimuli [69]. IL-10 has a protective role towards periodontal
tissue destruction, inhibiting both matrix metalloprteinases
(MMP)and receptor activator for nuclear factor-κB (RANK)
systems [159, 160]. Therefore the IL10 -592 R-allele carriers
may be less protected against bacterial challenge.
Table 8 summarizesthecase-controlstudiesinvestigating
genetic polymorphisms in the IL10 gene in association with
CP susceptibility. The carriage rates of the IL10 -1087 R-
allele vary between 44% and 81% in Caucasians. The -1087
locus has not been associated with CP susceptibility in most
of Caucasian populations. However, the -1087 N-allele was
associated with CP in Swedish Caucasians [65].
The IL10 -819 polymorphism has been correlated with
CPinBraziliansbutnotinotherpopulations[67].Untilnow
allthreestudiesontheIL10-592polymorphismhavefounda
higher R-allele carriage rate in CP patients [67–69]. The IL10
-592 R-allele carriage rates varied in diﬀerent populations
between 68% and 75% in CP patient and between 41% and
51% in controls.
One study on Japanese CP patients (N = 34) and
controls (N = 52) analyzed haplotypes consisting of the IL10
-1087, -819, and -592 gene polymorphisms [161]. Only hap-
lotype frequencies were reported and no separate genotype
frequencies were presented. No signiﬁcant diﬀerences for the
carriage rates of the haplotypes of the IL10 gene were found
between patients and controls. Striking was the complete
absence of the N-allele carriage at position -1087 among the
Japanese, in contrast to Caucasians (Table 8), where the -
1087 N-allele is the most occurring variant [65, 161].
For conclusion, IL10 -592 R-allele carriage rates have
been associated with CP susceptibility and the results have10 International Journal of Dentistry
Table 10:ThevitaminDreceptor(VDR)genepolymorphismsandcarriage rateoftheRare(R)-alleleincase-controlstudiesandassociation
with susceptibility to chronic periodontitis.
Patients Controls
VDR gene Ethnicity n R-allele n R-allele Associated Reference
polymorphism of subjects carriage carriage with periodontitis
Taq1 T>C
Caucasian 57 49% 100 78% + B r e t te ta l . 2005 [10]
Caucasian 58 53% 140 63% +3 Nibali et al. 2008 [81]
Chinese1 24 4% 39 5% − Sun et al. 2002 [82]
Japanese 74 11% 94 23% +4 Tachi et al. 2003 [83]
Brazilian 69 67% 44 45% + (+5) de Brito et al. 2004 [84]
Turkish 72 50% 102 42% − (+6) Gunes et al. 2008 [85]
Bsm1 A>G
Japanese1 52 21% 55 20% − Yoshihara et al. 2001 [80]
Japanese 17 23% 802 19% − (+7) Naito et al. 2007 [86]
Brazilian 69 86% 44 82% − (+5) de Brito Junior et al. 2004 [84]
Turkish 72 86% 102 91% − (+6) Gunes et al. 2008 [85]
Fok1 A>G Japanese 74 63% 94 54% − Tachi et al. 2003 [83]
Japanese 17 47% 806 69% −(+7) Naito et al. 2007 [86]
Apa1 G>T Japanese 17 30% 806 53% − (+7) Naito et al. 2007 [86]
Turkish 72 54% 102 61% − (+6) Gunes et al. 2008 [85]
nr = not reported. − = association not found. + = association found.
1Cases diagnosed as adult periodontitis.
2Control group consists of patients without severe periodontitis.
3The N/N genotype is associated with periodontitis in smokers.
4The N-allele is associated with periodontitis, also when adjusted for smoking and diabetes.
5The Bsm1/Taq1 N/N haplotype is associated with periodontitis.
6The Apa1/Bsm1/Taq1 haplotype is associated with severe periodontitis.
7The Apa1/Bsm1/Fok1 haplotype is associated with severe periodontitis.
been replicated [67–69]. Therefore we conclude that the
IL10 -592 polymorphism may be a genetic marker for CP
susceptibility.
4.6. Polymorphisms in the FcγRG e n e .Leukocyte receptors
for the constant (or Fc-) part of immunoglobulin (FcR) link
cellular and humoral parts of the immune system, which are
considered essential for the host defense against bacteria.
FcγRs are found on a wide variety of immune cells
in the periodontal tissues [162]. FcγRs are likely to play
a role in the pathogenesis of periodontitis [163]. Microor-
ganisms and bacterial antigens, opsonized with antibody,
can be phagocytosed via FcγR on neutrophils or inter-
nalized via FcγR by a variety of antigen presenting cells,
including monocytes, macrophages, and B cells. T cells
and natural killer cells may become activated, when IgG-
opsonized bacteria are bound to these cells via FcγR; a
variety of cytokines and chemokines may also be released
[164].
The FcγR genes are found on chromosome 1 and encode
3 main receptor classes: FcγRI (CD64), FcγRII (CD32), and
FcγRIII (CD16). These classes are further subdivided into
subclasses: FcγRIa and b, FcγRIIa, b, and c, and FcγRIIIa and
b. Structural and functional diﬀerences in FcγRIIa, IIIa, and
b have been described [164, 165].
The studies that have investigated the FcγRIIa, FcγRIIIa,
and FcγRIIIb polymorphisms in relation to periodontitis are
summarized in Table 9. Several studies have investigated the
FcγRIIa polymorphisms in relation to CP. In Caucasians,
the carriage rate of the FcγRIIa R-allele is relatively high:
63%–76%[70–73]andinAsianpopulationsthecarriagerate
is lower: 36%–62% (Table 9). In general, the FcγRIIa poly-
morphisms are not associated with CP. However, Yamamota
et al. [72] observed a decreased prevalence of the FcγRIIa
R-allele among Caucasian CP patients and controls in a
large case-control study. Homozygosity for the N-allele was
signiﬁcantly more prevalent in smoking CP patients [72].
Al o w e rR-allele carriage rate of the FcγRIIIa gene is seen
in Japanese in comparison to the Caucasians. In a Japanese
population it was found that the FcγRIIIa R-allele was over-
represented in patients with periodontal disease recurrence
[78]. In contrast, another Japanese study showed that the
FcγRIIIa N-allele was overrepresented in patients with severe
p e r i o d o n t i t i sv e r s u ss u b j e c t swi t hm o d e r a t ed i s e a s e[ 76]. But
none of the studies have associated the FcγRIIIa polymor-
phisms with CP susceptibility. It is apparent that there are
conﬂicting results and comparisons between the diﬀerent
studies are diﬃcult as the prevalences of FcγR genotypes
diﬀer among subjects of diﬀerent ethnic background.
T h ec a r r i a g er a t eo ft h eFcγRIIIb R-allele in Caucasians
was relatively high (>75%) and in Asians some what lower
(55%–74%). In Caucasians no associations have been found
between the FcγRIIIb R-allele carriage and CP susceptibility.
However, in one Japanese study the R-allele carriage has
been associated with CP susceptibility [79]. Two studies of
Kobayashi et al. [74, 76] have shown an association with CP
diseaserecurrenceandseverityincombinationwithFcγRIIIa
N-allele.International Journal of Dentistry 11
Table 11: CD14, TLR2, and TLR4 gene polymorphisms and carriage rate of the Rare (R)-allele in case-control studies and association with
susceptibility to chronic periodontitis.
Patients Controls
Ethnicity n R-allele n R-allele Associated Reference
of subjects carriage carriage with periodontitis
CD14 -2601C>T
Caucasian 135 74% 207 70% − Holla et al. 2002 [87]
Caucasians 70 66% 75 76% − (+3) Folwaczny et al. 2004 [88]
Caucasian 60 67% 39 77% +4 Donati et al. 2005 [46]
Caucasian2 100 74% 99 71% +5 Laine et al. 2005 [89]
Caucasian 95 75% 94 77% − James et al. 2007 [90]
Caucasian 51 47% 178 57% − (+6) Tervonen et al. 2007 [13]
Caucasian 60 67% 80 64% − Schulz et al. 2008 [91]
Caucasian2 72 76% 35 80% − Nicu et al. 2009 [92]
Non-Caucasian2 33 64% 22 86% −
Japanese 163 75% 104 82% − (+7) Yamazaki et al. 2003 [93]
CD14 -1359 Caucasian 135 43% 207 42% − Holla et al. 2002 [87]
Caucasian 95 38% 94 35% − James et al. 2007 [90]
TLR2 Arg677Trp
Caucasian 122 0% 122 0% − Folwaczny et al. 2004 [88]
Caucasian 83 0% 106 0% − Berdeli et al. 2007 [94]
Japanese 97 0% 100 0% − Fukusaki et al. 2007 [95]
Chinese 50 100% 100 100% − Zhu et al. 2008 [96]
TLR2 Arg753Gln
Caucasian 122 3% 122 4% − Folwaczny et al. 2004 [88]
Caucasian 83 13% 106 13% − Berdeli et al. 2007 [94]
Japanese 97 0% 100 0% − Fukusaki et al. 2007 [95]
Chinese 50 0% 100 6% − Zhu et al. 2008 [96]
TLR2 -183 Japanese 97 0% 100 1% − Fukusaki et al. 2007 [95]
TLR2 -148 Japanese 97 0% 100 1% − Fukusaki et al. 2007 [95]
TLR2 -146 Japanese 97 0% 100 1% − Fukusaki et al. 2007 [95]
TLR2 +1350 Japanese 97 40% 100 28% − Fukusaki et al. 2007 [95]
TLR2 +2343 Japanese 97 0% 100 3% − Fukusaki et al. 2007 [95]
TLR4 Asp299Gly
Caucasian 122 4% 122 3% − Folwaczny et al. 2004 [88]
Caucasian 57 11% 100 7% − B r e t te ta l . 2005 [10]
Caucasian2 100 10% 99 9% − Laine et al. 2005 [89]
Caucasian 83 5% 106 6% − Berdeli et al. 2007 [94]
Caucasian 171 14% 218 11% − Holla et al. 2007 [97]
Caucasian 95 19% 94 17% − James et al. 2007 [90]
Caucasian 51 25% 178 20% − Tervonen et al. 2007 [13]
Caucasian 60 13% 80 9% − Schulz et al. 2008 [91]
Japanese 97 0% 100 0% − Fukusaki et al. 2007 [95]
Chinese 50 0% 100 0% − Zhu et al. 2008 [96]
TLR4 Thr399Ile
Caucasian 122 4% 122 4% − Folwaczny et al. 2004 [88]
Caucasian 57 7% 100 18% − B r e t te ta l . 2005 [10]
Caucasian2 100 10% 99 9% − Laine et al. 2005 [89]
Caucasian 83 4% 106 5% − Berdeli et al. 2007 [94]
Caucasian 171 14% 218 10% − Holla et al. 2007 [97]
Caucasian 95 22% 94 20% − James et al. 2007 [90]
Caucasian 60 13% 80 9% − Schulz et al. 2008 [91]
Japanese 97 0% 100 0% − Fukusaki et al. 2007 [95]
Chinese 50 0% 100 0% − Zhu et al. 2008 [96]12 International Journal of Dentistry
Table 11: Continued.
Patients Controls
Ethnicity n R-allele n R-allele Associated Reference
of subjects carriage carriage with periodontitis
TLR4 +3528 Japanese 97 0% 100 2% − Fukusaki et al. 2007 [95]
TLR4 +3525 Japanese 97 26% 100 29% + Fukusaki et al. 2007 [95]
TLR4 +4022 Japanese 97 0% 100 1% − Fukusaki et al. 2007 [95]
TLR4 +4529 Japanese 97 2% 100 1% − Fukusaki et al. 2007 [95]
nr = not reported. − = association not found. + = association found.
1Also refered as -159.
2Cases diagnosed as adult periodontitis.
3The N-allele is associated with periodontitis in women.
4The N-allele is associated with CP.
5The R/R genotype is associated with CP also after correcting for age, gender, smoking, and presence A. actinomytemcomitans and P. gingivalis.
6The R-allele is associated with disease severity.
7The R-allele associated with early disease development.
Initially, polymorphisms in the FcγR genes were sug-
gested to play a role in periodontitis [166]; however in the
present review on the susceptibility to CP, only one study out
oftenfoundCPtobeassociatedwithFcγRIIapolymorphism
in smokers [72], and one out of nine studies with FcγRIIIb
[79]. Therefore we conclude that the reported FcγR gene
polymorphisms are not associated with CP susceptibility.
However, to date no large-scale epidemiological investiga-
tions are available, and subsequently no clear and convincing
data is presented to assign the FcγR gene polymorphisms as
risk factors for CP.
4.7. Polymorphisms in the VDR Gene. Vitamin D plays a
role in bone metabolism. Since alveolar bone resoption is a
majorcharacteristicofperiodontaldisease,itisplausiblethat
mediators of bone metabolism like the vitamin D receptor
(VDR) and its’ genetic polymorphisms play a role in CP
susceptibility. In addition to mediating bone homeostasis,
vitamin D and its receptor play a role in phagocytosis by
monocytes and aﬀect monocyte diﬀerentiation [167].
The human VDR gene is localized on chromosome
12q12–q14. Genetic polymorphisms in the VDR gene have
also been associated with infectious diseases, in particular
tuberculosis[168,169].ThemechanismsbywhichVDRgene
polymorphisms may inﬂuence CP susceptibility have not
beenclariﬁedyet.TheTaq1,Bsm1,andApa1 polymorphisms
do not change the translated protein whereas the Fok1
polymorphismmaybefunctionalcreatinganadditionalstart
codon (ACG to ATG) [170].
Several studies have identiﬁed VDR polymorphisms in
relation to CP at RFLP positions Taq1, Bsm1, Fok1, and Apa1
(Table 10)[ 10, 80–86]. Most of the studies on the SNPs of
the VDR gene have found associations with CP, however not
always unconditionally (Table 10).
The carriage rates of the VDR Taq1 R-allele range
between 42% and 78% across diﬀerent ethnic populations,
except in Asian populations where lower rates (4%–23%)
have been reported (Table 10). Not the Taq1 R-allele but
the N-allele has been associated with CP susceptibility
in several studies (Table 10). Another VDR polymorphism
(Bsm1) showed no association with CP as a single SNP but
in diﬀerent haplotype combinations with the other VDR
polymorphisms [84–86].
The VDR gene is an interesting candidate gene for
its association with periodontitis, because it aﬀects both
bone metabolism and immune functions. The VDR Taq1
SNP may be associated with CP susceptibility as a single
polymorphism or in combination with other VDR gene
polymorphisms.
4.8. Polymorphisms in the Pattern Recognition Receptor Genes.
The innate immune system recognizes pathogen-associated
molecular patterns (PAMPs) that are expressed on microor-
ganisms, but not on host cells. Extra- and intracellular
receptorslikeCD14,CARD15,andToll-likereceptors(TLRs)
recognize PAMPs of Gram-positive and Gram-negative bac-
teria and mediate the production of cytokines necessary for
further development of eﬀective immunity. Both TLR2 and
TLR4 use CD14 as a coreceptor.
4.8.1. Polymorphisms in the CD14 Gene. The gene for CD14
is located on chromosome 5q21–q23. The CD14 -260 (-
159) promotor polymorphism is located upstream from
the major transcriptional site, aﬀecting the transcriptional
activity and CD14 density [171]. Individuals homozygous
for the R-allele have increased serum levels of soluble (s)
CD14 and an increased density of CD14 in monocytes [171].
The CD14 -260 R-allele has previously been associated with
increased risk of myocardial infarction [171]a n dC r o h n ’ s
disease [172]. Given that the CD14 –260 N-allele leads to a
reduced expression of the CD14 receptor it is assumed that
individuals carrying the N-allele may be more susceptible to
CP since they are less protected by the CD14 receptor [173].
Carriage rate of the CD14 –260 R-allele varies in diﬀerent
ethinic populations from 47% to 82%. Eight studies have
investigated the CD14 -260 polymorphism in Caucasian
CP subjects (Table 11), but the results are conﬂicting. Two
studies found an association with the N-allele and another
study with the R-allele whereas ﬁve studies did not ﬁnd any
association with the CP susceptibility [87, 93].
Results for another polymorphism (position -1359)
in the CD14 gene have also been reported [87, 90]; noInternational Journal of Dentistry 13
Table 12: Miscellaneous candidate genes and the corresponding encoded proteins studied in relation to susceptibility to chronic
periodontitis and reported association.
Polymorphism Coded protein Reference Associated
in gene with periodontitis
ACE Angiotensin-converting enzyme Holla et al. 2001 [98] − (+1)
BPI Bactericidal/permeability-increasing protein Glas et al. 2006 [99] −
CARD15 (NOD2) Caspase recruitment domain-15 Folwaczny et al. 2004 [100] −
Laine et al. 2004 [101] −
CCR5 Chemokine receptor-5
Folwaczny et al. 2003 [102] −
Wohlfahrt et al. 2006 [59] −
Savarrio et al. 2007 [103] −
COL1A1 Type 1 collagen Sakellari et al. 2006 [12] −
COX-2 Cyclooxygenase-2 Ho et al. 2008 [104]+
Xie et al. 2009 [105]+
CTLA-4 Cytotoxic T-lymphocyte antigen-4 Wohlfahrt et al. 2006 [59] −
DEFB1 Human β . defensin  β .1 Wohlfahrt et al. 2006 [59] −
eNOS Endothelial nitric oxide synthase Berdeli et al. 2006 [106]+
ER2 Estrogen receptor-2 Zhang et al. 2004 [107] −
E-selectin E-selectin Houshmand et al. 2009 [108]+
ET1 Endothelin-1 Holla et al. 2001 [98] −
FasL Fas ligand Wohlfahrt et al. 2006 [59] −
FBR Fibrinogen Sahingur et al. 2003 [109]+ 2
FcγRIIb Fcγ receptor IIb Yasuda et al. 2003 [110]+
Kobayashi et al. 2007 [19]+
GSTM1 Glutathione-S-transferase M1 Concolino et al. 2007 [111]+
GSTT1 Glutathione-S-transferase T1 Concolino et al. 2007 [111] −
ICAM-1 Intercellular adhesion molecule-1 Wohlfahrt et al. 2006 [59] −
ICOS Inducible costimulator Wohlfahrt et al. 2006 [59] −
IFNG Interferon γ Hooshmand et al. 2008 [52] −
Reichert et al. 2008 [112] −
IFNGR1 Interferon γ receptor-1 Fraser et al. 2003 [113] − (+3)
Babel et al. 2006 [58] −
IL2 Interleukin-2 Scarel-Caminaga et al. 2002 [114] −
IL12 Interleukin-12 Reichert et al. 2008 [112] −
IL12RB2 Takeuchi-Hatanaka et al. 2008 [115] −
IL16 Interleukin-16 Folwaczny et al. 2005 [116] −
IL18 Interleukin-18 Folwaczny et al. 2005 [117] −
IL24 Interleukin-24 Savarrio et al. 2007 [103] −
Lactoferrin Lactoferrin Wu et al. 2009 [118] −
L-selectin L-selectin Houshmand et al. 2009 [108] −
LTA Lymphotoxin-α Holla et al. 2001 [98]+
Fassmann et al. 2003 [44] − (+4)
MBL Mannose binding lectin Louropoulou et al. 2008 [119] −
Tsutsumi et al. 2009 [120] −
MMP1 Matrix metalloproteinase-1
de Souza et al. 2003 [121] − (+5)
Holla et al. 2004 [122] −
Itagaki et al. 2004 [123] −
Astolﬁ et al. 2006 [124] −
Cao et al. 2006 [125]+
Pirhan et al. 2008 [126]+
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Table 12: Continued.
Polymorphism Coded protein Reference Associated
in gene with periodontitis
MMP2 Matrix metalloproteinase-1 (gelatinase A) Holla et al. 2005 [128] −
Gurkan et al. 2008 [129] −
MMP3 Matrix metalloproteinase-3 Itagaki et al. 2004 [123] −
Astolﬁ et al. 2006 [124]+
MMP9 Matrix metalloproteinase-9
de Souza et al. 2005 [130] −
Holla et al. 2006 [131] −
Keles et al. 2006 [132]+
Gurkan et al. 2008 [129] −
MMP12 Matrix metalloproteinase-12 Gurkan et al. 2008 [129] −
MPO Myeloperoxidase Meisel et al. 2002 [133] − (+6)
NAT2 N-acetyltransferase-2 Meisel et al. 2000 [134]+
Kocher et al. 2002 [135] −
OPG Osteoprotegerin
Wohlfahrt et al. 2006 [59] −
Wagner et al. 2007 [14] −
Baioni et al. 2008 [136] −
Park et al. 2008 [137] − (+7)
OPN Osteopontin Wohlfahrt et al. 2006 [59] −
PAI1 Plasminogen-activator-inhibitor-1 Holla et al. 2002 [138]+
Gurkan et al. 2007 [139] −
RAGE Receptor for advanced glycation end products Holla et al. 2001 [140]+
RANTES Regelated on activation, normal T cells expressed and secreted Savarrio et al. 2007 [103] −
S100A8 Calprotectin Li et al. 2007 [141]+ 8
SFTPD Surfactant protein D Glas et al. 2008 [142] −
TGFB1 Transforming growth factor-β1
Holla et al. 2002 [143] −
de Souza et al. 2003 [144] −
Atilla et al. 2006 [145]+
Babel et al. 2006 [58]+ 9
TIMP2 Tissue inhibitor of matrix metalloproteinase de Souza et al. 2005 [130] −
TNFR2 Tumor necrosis factor receptor-2 Shimada et al. 2004 [146]+
t-PA Tissue plasminogen-activator Gurkan et al. 2007 [139] −
− = association not found. + = association found.
1in combination with LTA.
2R-allele associated with higher serum ﬁbrinogen.
3R-allele in combination with smoking.
4N-allele protective in combination with TNFA-308.
5R-allele associated in non-smokers.
6R-allele protective for females.
7950T and 1181G haplotype is associated with CP.
8N-allele of rs3795391and rs3806232 is associated with CP in Chinese males.
9R-allele of codon 25 associated with CP.
association with CP susceptibility was found. However a
higher frequency of the N-allele and the N/N genotype of
the CD14 -1359 polymorphism was found in patients with
severe periodontal disease than in patients with moderate
periodontitis (Table 11)[ 87].
We conclude that the CD14 -260 polymorphism may be
associated with CP susceptibility.
4.8.2. Polymorphisms in the TLR2 and TLR4 Genes. TLR
2 and TLR4 genes map on chromosome 4q32 and 9q32-
q33, respectively. TLR2 Arg677Trp and Arg753Gln gene
polymorphisms have been reported to change the ability
of TLR2 to mediate a response to bacterial components
[174]. Two common cosegregating missense polymorphisms
of TLR4, Asp299Gly and Thr399Ile, aﬀect the extracellular
domain of the TLR4 protein, leading to an attenuated
eﬃcacy of LPS signalling and a reduced capacity to elicit
inﬂammation [175]. The TLR4 Asp299Gly gene polymor-
phism has been correlated with sepsis and infections caused
by Gram-negative bacteria [176]. The above named TLR
polymorphisms have been studied by several groups in
association with periodontitis (Table 11)[ 10, 13, 89–91, 94–
97, 177]. However, in spite of the perceived importance of
these functional TLR polymorphisms, no relation with CPInternational Journal of Dentistry 15
has been observed. Nine SNPs in the TLR 2 and TLR4 genes
have been studied by Fukusaki et al. [95] in a Japanese
population, and TLR4 +3725 polymorphism was found to
be associated with CP.
Interestingly, the TLR2 677 loci was not polymorphic
in Caucasian and Japanese populations [94, 95, 177], but
the heterozygotic genotype was found in 100% of the Han
Chinese [96]. The TLR2 753 and the TLR4 polymorphisms
were not or in very low percentage polymorphic in Asian
populations.InCaucasianpopulationstheTLR4299and399
carriage rates of the R-allele ranged between 4% and 25%
(Table 11).
Although the pattern recognition receptor genes seem
good candidates for their association with periodontitis,
investigations have not yielded any strong indications that
they might be associated with CP susceptibility.
4.9. Polymorphisms in Miscellaneous Genes. Miscellaneous
candidate gene polymorphisms that have been studied in
relation to CP are listed in Table 12. These are not discussed
in detail as the other candidate genes above, since mainly
negative results and/or too few studies are published for a
meaningful analysis. However, Table 12 illustrates the variety
of candidate genes and the diﬃculty in interpreting results; if
positive results are reported, these are often in subgroups or
conditionally.
5. Discussion and Conclusions
Case-control association study design is considered a pow-
erful method in detecting high frequently occurring, small-
eﬀect gene polymorphisms. However, this study design is
susceptible to a variety of potential methodological ﬂaws. An
important concern is selection of case and control subjects
because it has a great impact on study outcome. To be
able to detect genetic polymorphisms playing a role in
disease predisposition, strict phenotype classiﬁcation should
be employed during the selection procedure of the study
subjects. Importantly, the clinical symptoms like deepening
of the periodontal pocket, loss of attachment, and alveolar
bone loss are same in diﬀerent forms of periodontal diseases.
Also deﬁnition of control subjects may vary in diﬀerent
studies. Some reports characterize their control subjects
as healthy, while others describe their control subjects as
gingivitis patients or population controls. Inaccuracy in
disease classiﬁcation of CP makes the case-control studies
and replication of the studies diﬃcult.
Another possible bias in case-control studies is the
diversity of ethnic background of study cohorts. Since
genotype and allele frequencies may diﬀer between diﬀerent
ethnic populations [178], case and control subjects should
be selected on the basis of the same ethnic background. A
geneticriskfactorfordiseasesusceptibilityinonepopulation
may not be a risk factor in the other population.
From the current review, it became clear that a fairly
large number of studies on CP susceptibility are limited
by their sample size and power. Subsequently, no gene
polymorphism has, as yet, been deﬁnitely shown to be a
risk factor for CP susceptibility. Small sample size studies
are greatly underpowered, since most associations refer to
small odds ratio’s (range 1.1–1.5) and greatly contribute
to the risk for false positive or negative results [179]. For
instance, approximately 2000 cases and 2000 controls would
be required to provide 80% power to detect an odds ratio of
1.5 at a R-allele frequency of 0.1 and at an appropriate level
of signiﬁcance [180]. However many disease susceptibility
polymorphisms will confer an odds ratio less than 1.5,
requiring larger patient cohorts. Suﬃcient number of cases
and controls must be recruited in order to minimize the
risk of identifying false positive associations that are due
to chance alone or, conversely, of failing to detect a true
association between a polymorphism and a disease (false
negatives).
Typical for the multifactorial and polygenic complex
diseasesisthateachgeneticpolymorphismhasgenerallyonly
am o d e s te ﬀect, and that the interaction of genes and their
polymorphisms with each other (gene-gene interaction) and
with environmental factors (gene-environment interaction)
potentially has inﬂuence on the observed phenotype. There-
fore, multivariate analyses should be included to generate
odds ratios taking into account next to age and gender-
established risk factors like smoking, microbial factors, and
eventually interaction with other gene polymorphisms.
In case-control studies selection of candidate genes and
their polymorphisms is based on ap r i o r iknowledge of
disease pathogenesis and phenotypes. Consequently, one of
the greatest challenges in candidate gene studies remains
the intelligent selection of candidate genes and their poly-
morphisms. However the amount of knowledge, to date, is
enormous and eﬀective computer-based methods may be
helpful for deciding ap r i o r iwhich genes, polymorphisms,
and combinations (haplotypes) have the greatest chance of
inﬂuencing disease susceptibility [181, 182]. Most genetic
research on CP susceptibility has focused sofar on gene
polymorphisms that play a role in the recognition and clear-
ance of bacteria by the immune system, tissue destructive
processes, or metabolic mechanisms.
Meta-analyses may be a helpful approach in rationaliz-
ing the results from several small and conﬂicting studies.
Once a considerable amount of studies are available, meta-
analyses may be performed to pool data from diﬀerent
studies and determine allele frequencies in the diﬀerent
populations. However, meta-analyses may still have inherent
problems such as including individual studies that employ
widely diﬀerent phenotype criteria, and publication bias.
Previously, it has been demonstrated that molecular genetic
research is sensitive to “negative” publication bias [183].
Evidently, further studies on gene polymorphisms in CP
susceptibility are needed employing large amounts of indi-
viduals. Deﬁnite conclusions can be drawn on basis of
multiple, large-scale studies. Consortia and collaborative
studies may help to defeat the limitations of the individual
studies.
In conclusion, research on genetic polymorphisms in
the recent years has had limited success in unravelling
signiﬁcant and reproducible genetic factors for susceptibility
to CP. Taken together the data published so far on gene
polymorphisms in CP, we conclude that at this point there16 International Journal of Dentistry
is a relatively large variation among the various studies for
the R-allele carriage rates, even if the study populations are
of the same ethnic background. Nevertheless, some evidence
is emerging that polymorphisms in the IL1, IL6, IL10, VDR,
and CD14 genes may be associated with CP susceptibility in
certain populations. Future studies should apply more strict
disease classiﬁcation, larger study cohorts, adjust for relevant
risk factors in CP, and include analysis of multiple genes and
polymorphisms. Novel statistical methods may allow a better
assessment of multiple genes and polymorphisms within the
same pathway and interactions with environmental factors.
The possibility to include data from multiple genes and
polymorphisms or haplotypes and environmental data, and
to model their interactions, will give us a better assessment
of CP and its pathophysiology.
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